“…Nonetheless, PDT still serves as a fringe cancer treatment option due to many limitations, especially a lack of an ideal clinical PDT formulation [6]. One crucial issue is that most classic PS molecules are hydrophobic and prone to aggregate in aqueous condition, leading to a severe self-quenching effect, and therefore drastically reducing 1 O 2 generation as well as the therapeutic efficacy [7,8]. Besides, problems including difficult intravenous delivery [6] and low selectivity toward tumor areas remain poorly solved [9].…”